Welcome to our dedicated page for Mativ Holdings news (Ticker: $MATV), a resource for investors and traders seeking the latest updates and insights on Mativ Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mativ Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mativ Holdings's position in the market.
Mativ Holdings, Inc. reported earnings for the first quarter of 2024, excluding Engineered Papers business sales. Sales increased sequentially by 10.6% to $500.2 million. GAAP loss was $(28.0) million with Adjusted EBITDA down 6% at $45.8 million. Filtration & Advanced Materials segment sales decreased by 8%, and Sustainable & Adhesive Solutions segment sales were down 9%. The company is focused on reducing costs, streamlining operations, and delivering improved EBITDA for 2024.
